We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-3.5%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$128B
AUM Growth
-$140B
Cap. Flow
-$131B
Cap. Flow %
-102.41%
Top 10 Hldgs %
21.91%
Holding
5,876
New
1,592
Increased
605
Reduced
2,310
Closed
907

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.85B
2
MSFT icon
Microsoft
MSFT
+$1.75B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.22B
4
AMZN icon
Amazon
AMZN
+$1.04B
5
IYR icon
iShares US Real Estate ETF
IYR
+$924M

Sector Composition

Rank Sector Weight
1 Technology 22.06%
2 Financials 14.44%
3 Healthcare 10.25%
4 Consumer Discretionary 9.7%
5 Communication Services 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMGMW
4251
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$22K ﹤0.01%
+99,000
New +$33.7K
MCOM
4252
DELISTED
micromobility.com Inc. Class A Common stock
MCOM
$22K ﹤0.01%
+1
New +$27.2K
NMTR
4253
DELISTED
9 Meters Biopharma
NMTR
$22K ﹤0.01%
+1,838
New +$25.1K
GTYH
4254
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$22K ﹤0.01%
6,830
-32,239
-83% -$149K
EWH icon
4255
iShares MSCI Hong Kong ETF
EWH
$1.25B
$21K ﹤0.01%
+927
New +$21.6K
JOAN
4256
DELISTED
JOANN, Inc. Common Stock
JOAN
$21K ﹤0.01%
+1,872
New +$21.1K
IVC
4257
DELISTED
Invacare Corporation
IVC
$21K ﹤0.01%
15,202
-25,650
-63% -$54.9K
TMBR
4258
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$21K ﹤0.01%
+1,072
New +$17.9K
QTNT
4259
DELISTED
Quotient Limited Ordinary Shares
QTNT
$21K ﹤0.01%
418
-7,519
-95% -$449K
ACLX
4260
DELISTED
Arcellx
ACLX
$20K ﹤0.01%
+1,479
New +$24.7K
AG icon
4261
First Majestic Silver
AG
$7.73B
$20K ﹤0.01%
1,491
-220
-13% -$2.58K
ALLT icon
4262
Allot
ALLT
$367M
$20K ﹤0.01%
2,482
-313
-11% -$2.85K
AMLX icon
4263
Amylyx Pharmaceuticals
AMLX
$2.31B
$20K ﹤0.01%
+1,559
New +$35.2K
AQB icon
4264
AquaBounty Technologies
AQB
$4.68M
$20K ﹤0.01%
532
-2,653
-83% -$92.3K
BMEA icon
4265
Biomea Fusion
BMEA
$88.2M
$20K ﹤0.01%
+4,485
New +$29.1K
GYRE icon
4266
Gyre Therapeutics
GYRE
$648M
$20K ﹤0.01%
4,014
LABU icon
4267
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$553M
$20K ﹤0.01%
65
+55
+550% +$20.7K
LZ icon
4268
LegalZoom.com
LZ
$1.35B
$20K ﹤0.01%
1,435
-195
-12% -$2.93K
NNBR icon
4269
NN Inc
NNBR
$257M
$20K ﹤0.01%
6,939
-44,940
-87% -$148K
PBFS icon
4270
Pioneer Bancorp
PBFS
$442M
$20K ﹤0.01%
+1,887
New +$20.7K
PRQR icon
4271
ProQR Therapeutics
PRQR
$251M
$20K ﹤0.01%
22,600
+22,580
+112,900% +$75.6K
SA
4272
Seabridge Gold
SA
$2.89B
$20K ﹤0.01%
+1,090
New +$18.6K
SMIN icon
4273
iShares MSCI India Small-Cap ETF
SMIN
$753M
$20K ﹤0.01%
+350
New +$20.1K
TSAT icon
4274
Telesat
TSAT
$570M
$20K ﹤0.01%
+1,241
New +$27.7K
TYRA icon
4275
Tyra Biosciences
TYRA
$1.97B
$20K ﹤0.01%
+1,915
New +$22.7K

Similar funds

Barclays's Q1 2022 Portfolio in Review

As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Barclays opened a new position in Stellantis worth $331M.

  • Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
  • Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
  • Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
  • Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
  • Barclays opened 1,592 new positions and closed 907 in Q1 2022.
  • Barclays's portfolio value fell 52% quarter-over-quarter to $128B.

Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.